Cargando…
Cholesterol-Lowering Drugs as Potential Antivirals: A Repurposing Approach against Flavivirus Infections
Flaviviruses, including Dengue (DENV), Zika (ZIKV), and Yellow Fever (YFV) viruses, represent a significant global health burden. The development of effective antiviral therapies against these viruses is crucial to mitigate their impact. This study investigated the antiviral potential of the cholest...
Autores principales: | Osuna-Ramos, Juan Fidel, Farfan-Morales, Carlos Noe, Cordero-Rivera, Carlos Daniel, De Jesús-González, Luis Adrián, Reyes-Ruiz, José Manuel, Hurtado-Monzón, Arianna M., Palacios-Rápalo, Selvin Noé, Jiménez-Camacho, Ricardo, Meraz-Ríos, Marco Antonio, Del Ángel, Rosa María |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10383882/ https://www.ncbi.nlm.nih.gov/pubmed/37515153 http://dx.doi.org/10.3390/v15071465 |
Ejemplares similares
-
Anti-flavivirus Properties of Lipid-Lowering Drugs
por: Farfan-Morales, Carlos Noe, et al.
Publicado: (2021) -
The Regulation of Flavivirus Infection by Hijacking Exosome-Mediated Cell–Cell Communication: New Insights on Virus–Host Interactions
por: Reyes-Ruiz, José Manuel, et al.
Publicado: (2020) -
An ivermectin – atorvastatin combination impairs nuclear transport inhibiting dengue infection in vitro and in vivo
por: Palacios-Rápalo, Selvin Noé, et al.
Publicado: (2023) -
Cholesterol-Rich Lipid Rafts as Platforms for SARS-CoV-2 Entry
por: Palacios-Rápalo, Selvin Noé, et al.
Publicado: (2021) -
The Nuclear Pore Complex: A Target for NS3 Protease of Dengue and Zika Viruses
por: De Jesús-González, Luis Adrián, et al.
Publicado: (2020)